행사/교육
Tuberculosis Drug Discovery & Development - New Strategies to Fight an Old Enemy
- 등록일2015-07-06
- 조회수3988
- 구분 국외
- 행사교육분류 행사
-
주관기관
Gordon Research Seminar\
-
행사장소
Melia Golf Vichy Catalan Business and Convention Center Girona, Spain
-
행사기간
2015-07-11 ~ 2015-07-12
- 원문링크
-
첨부파일
Application Deadline
This meeting is currently oversubscribed (full). You may still an application. However, it will only be considered by the Conference Chair if more seats become available due to cancellations.
Meeting Deion
Overview
The Gordon Research Seminar on Tuberculosis Drug Discovery & Development is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and ex new data and cutting edge ideas.
The of this meeting is to cover all aspects of TB drug development from bench to bedside: Identification of new drug targets, the development of new techniques to identify new drugs and screen for new drug targets, results from pre-clinical evaluation, and the clinical outcome of new drug and new combination therapies fighting Mycobacterium tuberculosis and its resistant forms.
Application Instructions
The meeting will feature approximately 10 talks and 2 poster sessions. All attendees are expected to actively participate in the GRS either by giving an oral presentation or presenting a poster. Therefore, all applications must include an abstract.
The Chairs will speakers from abstracts ted by April 11, 2015. Those applicants who are not chosen for talks and those who apply after the deadline to be considered for an oral presentation will be expected to present a poster. In order to participate, you must an application by the date indicated in the Application Deadline section above.
Meeting Program
| Saturday | |
| 1:30 pm - 4:30 pm | Arrival and Check-in |
| 3:00 pm - 3:15 pm | Introductory Comments by GRC Site Staff / Welcome by the GRS Conference Chair |
| 3:15 pm - 4:00 pm | Keynote Session: How to Find Mycobacterium tuberculosis' Achilles' Heel |
| Discussion Leaders: Eachan Johnson (Broad Institute of Massachusetts Institute of Technology and Harvard University, USA) and Laura Via (National Institute of Allergy and Infectious Diseases, USA) | |
| 3:15 pm - 3:45 pm | Dirk Schnappinger (Weill Cornell Medical College, USA) "Genetic Approaches to Facilitate TB Drug Development" |
| 3:45 pm - 4:00 pm | Discussion |
| 4:00 pm - 5:30 pm | Poster Session |
| 5:30 pm - 7:30 pm | New Targets and Their Evaluation |
| Discussion Leaders: Eleni Pitta (University of Antwerp, Belgium) and Carolina Trujillo (Weill Cornell Medical College, USA) | |
| 5:30 pm - 5:50 pm | Vijay Soni (Birla Institute of Technology and Science, India) "Mycobacterium tuberculosis N-Acetyl-Glucosamine-1-Phosphate Uridyltransferase (glmU) Is Critical for Survival Both in Early and Late Phase of Infections" |
| 5:50 pm - 6:00 pm | Discussion |
| 6:00 pm - 6:20 pm | Joanna Evans (University of Cape Town, South Africa) "A Pathway Approach to Identifying Vulnerable and Bactericidal Targets in Coenzyme A Biosynthesis inMycobacterium tuberculosis" |
| 6:20 pm - 6:30 pm | Discussion |
| 6:30 pm - 6:50 pm | Julien Vaubourgeix (Weill Cornell Medical College, USA) "Asymmetric Distribution of Irreversibly Oxidized, ClpB-Associated Proteins in Stressed Mycobacteria" |
| 6:50 pm - 7:00 pm | Discussion |
| 7:00 pm - 7:20 pm | Wilfried Moreira (National University of Singapore, Singapore) "A Target Mechanism-Based Whole Cell Screen Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria" |
| 7:20 pm - 7:30 pm | Discussion |
| 8:00 pm | Dinner |
| Sunday | |
| 7:30 am - 8:30 am | Breakfast |
| 9:00 am - 11:00 am | Keynote Session: How Do Drugs Get to Where We Need Them to Be? / Improving Current Strategies |
| Discussion Leaders: Tania Lupoli (Weill Cornell Medical College, USA) and Santiago Ramon Garcia(The University of British Columbia, Canada) | |
| 9:00 am - 9:30 am | Veronique Dartois (New Jersey Medical School, USA) "Pharmacokinetics, Pharmacodynamics and Tissue Distribution of Tuberculosis Drugs" |
| 9:30 am - 9:45 am | Discussion |
| 9:45 am - 10:05 am | Vaibhav Singh Bais (Indian Institute of Technology Kanpur, India) "Investigating the Inhibitory Potential of 2-Aminopurine Metal Complexes Against PknB" |
| 10:05 am - 10:15 am | Discussion |
| 10:15 am - 10:35 am | Jonathan Cox (University of Birmingham, United Kingdom) "Changing Strategies in Elucidating the Mode of Action of New Anti-Tubercular Compounds" |
| 10:35 am - 10:45 am | Discussion |
| 10:45 am - 10:55 am | Fraser Cunningham (GlaxoSmithKline, Spain) "Open Lab Foundation" |
| 10:55 am - 11:00 am | Discussion |
| 11:00 am - 12:30 pm | Poster Session |
| Coffee will be served in the poster area from 11:00 am - 11:30 am | |
| 12:30 pm | Lunch |
| 1:30 pm - 2:30 pm | Novel Non-Traditional Strategies |
| Discussion Leaders: Maikel Boot (VU Medical Center, The Netherlands) and Helena Boshoff (National Institutes of Health, USA) | |
| 1:30 pm - 1:50 pm | Xingji Zheng (University of British Columbia, Canada) "Natural Compounds Active Against Mycobacterium tuberculosis PtpA" |
| 1:50 pm - 2:00 pm | Discussion |
| 2:00 pm - 2:20 pm | Kelly Flentie (Washington University in St. Louis School of Medicine, USA) "Chemical Dissection of the Contribution of Lipid Composition Changes to Mycobacterium tuberculosisPersister Formation" |
| 2:20 pm - 2:30 pm | Discussion |
| 2:30 pm - 3:00 pm | Evaluation Period |
| Fill in GRS Evaluation Forms | |
| 3:00 pm | Seminar Concludes |
...................(계속)
☞ 자세한 내용은 내용바로가기 또는 첨부파일을 이용하시기 바랍니다.